title: Long-acting injectable antipsychotics: an underutilized treatment option.
abstract: In this issue, Kane and colleagues report on the efficacy of aripiprazole long-acting injection (LAI) in the treatment of an acute episode of schizophrenia. At 10 weeks of treatment, both psychopathology and functioning were improved in patients treated with aripiprazole compared to placebo, with an acceptable tolerability and safety profile. The outcomes suggest that aripiprazole long-acting is a viable treatment option for patients experiencing an acute episode of schizophrenia.
authors.affiliation: Technische Universitaet Muenchen, Psychiatry, Moehlstrasse 26, Muenchen, Bavaria 81675, Germany s.heres@lrz.tu-muenchen.de.
authors.forename: Stephan
authors.initials: S
authors.lastname: Heres
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage*; D000068180:Aripiprazole; D005260:Female; D006801:Humans; D008297:Male; D010879:Piperazines / Q000008:administration & dosage*; D015363:Quinolones / Q000008:administration & dosage*; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole